OpenAI, Google and Microsoft warn AI could aid biological weapon development, urge new laws
Leaders from OpenAI, Google DeepMind, Microsoft, and Anthropic urged the U.S. Congress to enforce stricter screening of synthetic DNA and RNA orders, warning AI could enable biological weapon development by bypassing current safeguards. The letter, signed by CEOs including Sam Altman and Demis Hassabis, highlights AI’s potential to help bad actors evade detection in genetic material purchases and design dangerous pathogens, despite existing screening tools having limitations.
Leaders from OpenAI, Google DeepMind, Microsoft, and Anthropic have called on the U.S. Congress to implement new laws requiring synthetic DNA and RNA providers to screen customer orders. In a public letter, CEOs Sam Altman (OpenAI), Demis Hassabis (Google DeepMind), Dario Amodei (Anthropic), and Mustafa Suleyman (Microsoft), alongside scientists and security experts, argue that AI tools could help malicious actors bypass current biosecurity checks, increasing risks of biological weapon development. The proposal comes as AI simplifies access to genetic information, potentially lowering barriers for dangerous research. Current safeguards, like software screening for 'sequences of concern,' may not fully prevent misuse, as AI can suggest modifications to evade detection. A 2023 Microsoft study found AI-powered protein design tools generated potentially hazardous gene sequences that slipped past existing screening systems. Commercial DNA synthesis, once limited to labs, is now automated and widely available, with companies selling custom genetic sequences for research, medicine, and diagnostics. While many providers enforce customer vetting, gaps remain, allowing unchecked orders. The letter warns that AI could accelerate the design of novel toxins or pathogens, even if biological expertise is still required for functional weaponization. The signatories emphasize that existing safeguards are insufficient, citing AI’s ability to propose dangerous protein structures undetected. They urge Congress to mandate pre-order screening for synthetic genetic material to prevent misuse, framing stronger regulations as critical to mitigating emerging biosecurity threats.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.